STKH

Business Context and Reporting Period

Company: Steakholder Foods Ltd. (STKH)
Reporting Period: Fiscal Year Ended December 31, 2024
Business Overview: Steakholder Foods is an Israeli deep-tech food company developing 3D printing machinery and plant-based premix blends to produce structured alternative protein products (meat and seafood analogs). The company operates on a B2B model, selling production machines and ingredients to food manufacturers. It is an emerging growth company with a limited operating history, having generated initial revenues only in late 2024.

Key Financial Metrics

Debt and Liquidity: The company has no significant long-term debt other than a $54 thousand loan to a partner (Wyler Farm). Total lease liabilities were $2.455 million as of December 31, 2024. The company raised approximately $6.4 million in financing activities during 2024.

Material Changes vs. Prior Period

• Revenue Generation: The company recognized initial revenue of $10,000 in 2024 from the sale of plant-based premix blends, compared to zero revenue in 2023.
• Expense Reduction: Total operating loss decreased by approximately 40% (from $14.2 million to $8.5 million). This was driven by a 50% reduction in Research and Development expenses (to $3.5 million) and a 49% reduction in Marketing expenses (to $1.4 million), attributed to cost-cutting measures and the recognition of a government grant.
• Discontinued Operations: The company recorded no loss from discontinued operations in 2024, compared to a $1.3 million loss in 2023, following the bankruptcy and deconsolidation of its Belgian subsidiary, Peace of Meat BV.
• Cash Position: Cash and cash equivalents declined by approximately $3.0 million year-over-year, reflecting continued negative operating cash flows.

Guidance, Outlook, Risks, and Unusual Items

Going Concern Warning: Management has expressed substantial doubt about the company's ability to continue as a going concern. With an accumulated deficit of $78.7 million and cash reserves of only $1.3 million, the company expects to continue incurring significant losses and requires substantial additional funding to sustain operations for the next 12 months.

Recent Financing (Subsequent Events):

• February 2025: Entered a securities purchase agreement raising approximately $1.25 million and established an $8 million equity line of credit (At-the-Money Offering Agreement).
• January 2025: Sold approximately $278,000 of ADSs under an existing ATM program.

Operational Milestones:

• Opened a full-scale Demonstration Center in September 2024.
• Secured purchase orders from Bondor Foods Ltd. and Wyler Farm Ltd. for premix blends.
• Announced a Memorandum of Understanding with Vegefarm Co. Ltd. for the sale of 3D printers.

Key Risks:

• Geopolitical: Ongoing war in Israel (conflicts with Hamas, Hezbollah, Iran) poses risks to operations, employee safety, and supply chains, though impact was deemed immaterial in 2024.
• Commercialization: Success depends on the market acceptance of 3D-printed alternative proteins and the ability to scale production.
• Liquidity: Failure to secure additional capital could force the company to cease operations.

Investor Verification Checklist

• Cash Runway: Verify the sufficiency of the $1.3 million cash balance plus the $8 million equity line of credit to fund operations through the next 12-18 months given the high burn rate.
• Revenue Sustainability: Assess whether the $10,000 revenue in 2024 represents a scalable trend or a one-time pilot transaction.
• Lease Restructuring: Confirm the execution of the March 2025 lease agreement that reduces rental expenses by 50% and eliminates the $2.4 million lease liability.
• Geopolitical Exposure: Monitor the impact of the ongoing conflict in Israel on the company's ability to retain key personnel and maintain its Rehovot facility.
• Dilution Risk: Evaluate the potential dilution from the $8 million equity line of credit and future fundraising requirements.